Kinesin expression in the central nervous system of humans and transgenic hSOD1G93A mice with amyotrophic lateral sclerosis

Neurodegenerative Diseases

Volumn 12, Issue 2, 2013, Pages 71-80

  Kuźma Kozakiewicz, Magdalena ^a   Chudy, Agnieszka ^b   Gajewska, Beata ^a,b   Dziewulska, Dorota ^a,c   Usarek, Ewa ^a   Barańczyk Kuźma, Anna ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Departments of Biochemistry   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Central nervous system; hSOD1G93A mutation; Kinesin expression; Neurodegeneration; Sporadic amyotrophic lateral sclerosis; Transgenic mice

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; KINESIN; KINESIN FAMILY MEMBER 1B; KINESIN FAMILY MEMBER 5A; KINESIN FAMILY MEMBER 5C; KINESIN FAMILY MEMBER C2; KINESIN FAMILY MEMBER C3; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MOTOR CORTEX; MOTOR NEURON DEGENERATION; MOUSE; NERVE CELL DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY CORTEX; SPINAL CORD; TRANSGENIC MOUSE; WILD TYPE;

EID: 84881131694     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000339529     Document Type: Article

References (39)

1. Haverkamp LJ, Appel V, Appel SH: Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707-719.
2. Mulder DW, Kurland LT, Offord KP, Beard CM: Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986; 36: 511-517.
3. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al: Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775.
4. Dal Canto MC, Gurney ME: Neuropathological changes in two lines of mice carrying a transgene for mutant human CuZn SOD and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis. Brain Res 1995; 676: 25-40.
5. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM: Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 1996; 93: 3155-3160.
6. El-Kadi AM, Soura V, Hafezparast M: Defective axonal transport in motor neurodisease, J Neurosci Res 2007; 85: 2557-2566.
7. Hirokawa N, Noda Y, Tanaka Y, Niwa S: Kinesin superfamily motor proteins and intracellular transport. Nature 2009; 10: 682-696.
8. Eschbach J, Dupuis L: Cytoplasmic dynein in neurodegeneration. Pharmacol Ther 2011; 130: 348-363.
9. Miki H, Okada Y, Hirikawa N: Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 2005; 15: 465-476.
10. Hirokawa N, Tekamura R: Molecular motors in neuronal development, intracellular transport and diseases. Curr Opin Neurol 2004; 14: 564-573.
11. Hanlon DW, Yang Z, Goldstein LS: Characterization of KIFC2, a neuronal kinesin superfamily member in mouse. Neuron 1997; 18: 439-451.
12. Saito N, Okada Y, Noda Y, Kinoshita Y, Kondo S, Hirokawa N: KIFC2 is a novel neuronspecific C-terminal type kinesin superfamily motor for dendritic transport of multivesicular body-like organelles. Neuron 1997; 3: 425-438.
13. Kanai Y, Okada Y, Tanaka Y, Harada A, Terada S. Hirokawa N: KIF5C, a novel neuronal kinesin enriched in motor neurons. J Neurosci 2000; 20: 6374-6384.
14. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Tekemura R, Yamazaki H, Hirokawa N: KIF1B, a novel microtubule plus enddirected monomeric motor protein for transport of mitochondria. Cell 1994; 79: 1209-1220.
15. Vale RD, Fletterick RJ: The design plan of kinesin motors. Annu Rev Cell Dev Biol 1997; 13: 745-777.
16. Hua W, Young EC, Fleming ML, Gelles J: Coupling of kinesin steps to ATP hydrolysis. Nature 1997; 388: 390-393.
17. Matsushita M, Yamamoto K, Mitsui K, Kanazawa H: Altered motor activity of alternative splice variations of the mammalian kinesin-3 protein KIF1B. Traffic 2009; 10: 1647-1654.
18. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Floeter MK, Budus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH: Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455-456.
19. Munch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G, Ludolph AC: Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004; 63: 724-726.
20. Mizuno N, Toba S, Edamatsu M, Watai- Nishii J, Kikkawa M: Dynein and kinesin share an overlapping microtubule-binding site. EMBO J 2004; 23: 2459-2467.
21. Brady ST, Pfister KK, Bloom GS: A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc Natl Acad Sci USA 1990; 87: 1061-1065.
22. Toyoshima I, Sugawara M, Kato K, Wada C, Hirota K, Hasegawa K, Kowa H, Sheetz MP, Masamune O: Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease. J Neurol Sci 1998; 159: 38-44.
23. Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Graham FL, Gaskell PC, Dearlove A, Pericak-Vance MA, Rubinsztein DC, Marchuk DA: A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 2002; 71: 1189-1194.
24. Ebbing B, Mann K, Starosta A, Jaud J, Schule R, Woehike G: Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet 2008; 17: 1245-1252.
25. Conforti L, Dell'Agnello C, Calvaresi N, Tortarolo M, Giorgini A, Coleman MP, Bendotti C: Kif1B-isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res 2003; 71: 732-733.
26. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate- phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
27. Teuchert M, Fischer D, Schwalenstoecker B, Habisch HJ, Bockers TM, Ludolph AC: A dynein mutation attenuates motor neuron degeneration in SOD1G93A mice. Exp Neurol 2006; 198: 271-274.
28. Kuźma-Kozakiewicz M, Usarek E, Ludolph AC, Barańczyk-Kuźma A: Mice with mutation in dynein heavy chain 1 do not share the same tau expression pattern with mice with SOD1-related motor neuron disease. Neurochem Res 2011; 36: 978-985.
29. Vershinin M, Brian C, Carter C, Razafsky DS, King SJ, Gross SJ: Multiple-motor based transport and its regulation by tau. Proc Natl Acad Sci USA 2007; 104: 87-92.
30. Dixit R, Ross LR, Goldman YE, Holzbaur EL: Differential regulation of dynein and kinesin motor proteins by tau. Science 2008; 319: 1086-1089.
31. Andreadis A: Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta 2005; 1739: 91-103.
32. Mandelkow E, Von Bergen M, Biernat J, Mandelkow EM: Structural principles of tau and Alzheimer paired helical filaments. Brain Pathol 2007; 17: 83-90.
33. Brandt R, Leger J, Lee G: Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 1999; 131: 1327-1340.
34. Georgieff IS, Liem RK, Couchie D, Mavilia C, Nunez J, Shelanski ML: Expression of high molecular weight tau in the central and peripheral nervous systems. J Cell Sci 1993; 105: 729-737.
35. Usarek E, Kuźma-Kozakiewcz M, Schwalenstöcker B, Kaźmierczak B, Münch C, Ludolph AC, Barańczyk-Kuźma A: Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 2006; 31: 597-602.
36. LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, Brady ST: The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res 2009; 87: 440-451.
37. Dupuis L, de Tapia M, Rene F, Lutz-Bucher B, Gordon JW, Mercken L, Pradier L, Loeffler J-P: Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons. Neurobiol Dis 2000; 7: 274-285.
38. Agosta F, Chio A, Cosottini M, De Stefano N, Faleni A, Mascalchi M, Rocca MA, Silani V, Tedeschi G, Filippi M: The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2010; 31: 1769-1777.
39. Barańczyk-Kuźma A, Usarek E, Kuźma- Kozakiewcz M, Kaźmierczak B, Gajewska B, Schwalenstocker B, Ludolph AC: Age-related changes in tau expression in transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 2007; 32: 415-421.